Last mentioned: Mar 18, 2026
STAT Analysis Released
Data confirms a 35% nosedive in Big Pharma antimicrobial R&D over the preceding 60 months.
Small Biotech Crisis
A wave of bankruptcies among small antibiotic developers highlights the 'broken market' for new treatments.
Market Exit Acceleration
Several large pharma entities announce the closure of infectious disease units to focus on chronic therapies.
Baseline Period
Major drugmakers maintain active antimicrobial pipelines before a steady five-year decline begins.
A new analysis reveals a 35% decline in antimicrobial R&D by major pharmaceutical companies over the last five years, highlighting a deepening crisis in the fight against drug-resistant superbugs. The exodus of large-scale investment underscores the persistent lack of economic incentives for developing life-saving antibiotics.
This page surfaces every story mentioning AMR Action Fund across our biotech coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running biotech beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where AMR Action Fund was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |